Edwards Lifesciences (NYSE:EW – Get Free Report) had its target price dropped by investment analysts at Evercore ISI from $92.00 to $89.00 in a note issued to investors on Friday, Benzinga reports. The brokerage currently has an “in-line” rating on the medical research company’s stock. Evercore ISI’s price objective would indicate a potential upside of […]